Pam Field, MS, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 20301 Golden Rd, Linwood, KS 66052 Phone: 913-636-3365 |
News Archive
Sinovac Biotech Ltd. (NYSE Amex: SVA), a leading provider of vaccines in China, today announced that the first lot of PANFLU.1, its H1N1 vaccine, has passed the lot release process of China's National Institute for the Control of Pharmaceutical and Biological Products and obtained the Certificate for the Release of Biological Products, which means the released vaccines are ready for delivery.
In a novel imaging study of sleeping toddlers, scientists at the University of California, San Diego Autism Center of Excellence report that a diminished ability of a young brain's hemispheres to "sync" with one another could be a powerful, new biological marker of autism, one that might enable an autism diagnosis at a very young age.
Novartis Pharmaceuticals Canada Inc. (Novartis) announced today that Afinitor(R) (everolimus), a once-daily oral cancer treatment, has been approved by Health Canada for patients with metastatic renal cell carcinoma (mRCC), also known as advanced kidney cancer, after failure of initial treatment with VEGF-receptor targeted therapies Sutent(R) (sunitinib) or Nexavar(R) (sorafenib).
In a major step forward in addressing the needs of homeless people in Vancouver who are living with mental illness, the Mental Health Commission of Canada (MHCC) and the PHS Community Services Society today officially opened the Bosman Hotel Community, providing stable housing and support to 100 residents.
The PARADIGM-HF trial has been stopped early for a benefit to patients that was overwhelmingly statistically significant.
› Verified 4 days ago